Vijaya Diagnostic Centre Limited (NSE:VIJAYA)

Market Cap	100.07B
Revenue (ttm)	6.81B
Net Income (ttm)	1.43B
Shares Out	102.64M
EPS (ttm)	13.92
PE Ratio	70.04
Forward PE	56.65
Dividend	2.00 (0.21%)
Ex-Dividend Date	Aug 30, 2024

Volume	277,592
Average Volume	345,071
Open	979.80
Previous Close	972.00
Day's Range	958.40 - 980.10
52-Week Range	730.00 - 1,275.00
Beta	-0.13
RSI	52.90
Earnings Date	May 8, 2025

About Vijaya Diagnostic Centre

Vijaya Diagnostic Centre Limited engages in the provision of diagnostic services for patients in India. It offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. The company also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 an...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1981
• Employees: 2,053
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIJAYA

Financial Performance

In 2024, Vijaya Diagnostic Centre's revenue was 6.81 billion, an increase of 24.39% compared to the previous year's 5.48 billion. Earnings were 1.43 billion, an increase of 20.41%.